A 6-month clinical study to evaluate the effect of a digital disease management tool in patients with T2DM

Study identifier:D1841C00004

ClinicalTrials.gov identifier:NCT03090464

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A real-world, point-of-care, randomized, parallel group, open, 6-month clinical study to evaluate the effect of a digital disease management tool in patients with type 2 diabetes mellitus

Medical condition

Type 2 Diabetes Mellitus

Phase

-

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

328

Study type

Observational

Age

18 Years - 99 Years

Date

Study Start Date: 08 May 2017
Primary Completion Date: 21 May 2018
Study Completion Date: 21 May 2018

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 May 2019 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria